Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting β2-agonists: addition of montelukast in an open-label pilot study

By Dupont Lieven   Potvin Emmanuel   Korn Dana   Lachman Albert   Dramaix Michèle   Gusman Julie   Peché Rudi  

Current Medical Research and Opinion, Vol. 21, Iss. 6, 2005-06 ,pp. : 863-870

Informa Healthcare

Access to resources Recommend Favorite

Relative systemic availability of budesonide in patients with asthma after inhalation from two dry powder inhalers

By Persson Gunnar   Ankerst Jaro   Gillen Michael   Bengtsson Thomas   Thorsson Lars  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1511-1517

Informa Healthcare

Access to resources Recommend Favorite

Evaluating Safety of Long-Acting Beta Agonists (LABAs) in Patients with Asthma

By  

Current Drug Safety, Vol. 5, Iss. 3, 2010-07 ,pp. : 245-250

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative Effects of Desloratadine versus Montelukast on Asthma Symptoms and Use of β₂-Agonists in Patients with Seasonal Allergic Rhinitis and Asthma

By  

International Archives of Allergy and Immunology, Vol. 130, Iss. 4, 2003-05 ,pp. : 307-313

Karger

Access to resources Recommend Favorite

Appropriate use of inhaled corticosteroid and long-acting ßß₂-adrenergic agonist combination therapy among asthma patients in a US commercially insured population

By Ye Xin   Gutierrez Benjamin   Zarotsky Victoria   Nelson Michael   Blanchette Christopher M.  

Current Medical Research and Opinion, Vol. 25, Iss. 9, 2009-09 ,pp. : 2251-2258

Informa Healthcare

Access to resources Recommend Favorite